Abstract:Physiological aging or DNA‐damaging agents increase expression of p16Ink4a and p21Cip1 expression and SA‐β‐Gal cell activity in osteoblasts, while simultaneously decreasing miR‐19a‐3p expression. Restoring miR‐19a‐3p expression using a miR‐19a‐3p mimic attenuates both p16Ink4a and p21Cip1 expression, as well as SA‐β‐Gal cell activity, in senescent osteoblasts. Aging is a major risk factor for most chronic diseases, including osteoporosis, and is characterized by an accumulation of senescent cells in various tissues. MicroRNAs (miRNAs) are critical regulators of bone aging and cellular senescence. Here, we report that miR‐19a‐3p decreases with age in bone samples from mice as well as in posterior iliac crest bone biopsies of younger versus older healthy women. miR‐19a‐3p also decreased in mouse bone marrow stromal cells following induction of senescence using etoposide, H2O2, or serial passaging. To explore the transcriptomic effects of miR‐19a‐3p, we performed RNA sequencing of mouse calvarial osteoblasts transfected with control or miR‐19a‐3p mimics and found that miR‐19a‐3p overexpression significantly altered the expression of various senescence, senescence‐associated secretory phenotype‐related, and proliferation genes. Specifically, miR‐19a‐3p overexpression in nonsenescent osteoblasts significantly suppressed p16Ink4a and p21Cip1 gene expression and increased their proliferative capacity. Finally, we established a novel senotherapeutic role for this miRNA by treating miR‐19a‐3p expressing cells with H2O2 to induce senescence. Interestingly, these cells exhibited lower p16Ink4a and p21Cip1 expression, increased proliferation‐related gene expression, and reduced SA‐β‐Gal+ cells. Our results thus establish that miR‐19a‐3p is a senescence‐associated miRNA that decreases with age in mouse and human bones and is a potential senotherapeutic target for age‐related bone loss. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

Loss of Rictor with Aging in Osteoblasts Promotes Age-Related Bone Loss

Rictor/mTORC2 Loss in Osteoblasts Impairs Bone Mass and Strength.

RhoA Promotes Osteoclastogenesis and Regulates Bone Remodeling Through Mtor-Nfatc1 Signaling.

MiR-138-5p Targets MACF1 to Aggravate Aging-related Bone Loss

mTORC1 Activation in Osteoclasts Prevents Bone Loss in a Mouse Model of Osteoporosis

MicroRNA-188 Regulates Age-Related Switch Between Osteoblast and Adipocyte Differentiation.

The mTORC2 Component Rictor Is Required for Load-Induced Bone Formation in Late-Stage Skeletal Cells

Mtorc1 Inhibits NF-κB/NFATc1 Signaling and Prevents Osteoclast Precursor Differentiation, in Vitro and in Mice

RhoA/Rock activation represents a new mechanism for inactivating Wnt/β-catenin signaling in the aging-associated bone loss

Osteocyte RANKL is required for cortical bone loss with age and is induced by senescence

The age-related characteristics in bone microarchitecture, osteoclast distribution pattern, functional and transcriptomic alterations of BMSCs in mice

A decrease in NAD+ contributes to the loss of osteoprogenitors and bone mass with aging

Inactivation of Regulatory-associated Protein of Mtor (raptor)/mammalian Target of Rapamycin Complex 1 (mtorc1) Signaling in Osteoclasts Increases Bone Mass by Inhibiting Osteoclast Differentiation in Mice.

Osteocyte-intrinsic mTORC1 signaling restrains trabecular bone accrual in mice.

MicroRNA‐19a‐3p Decreases with Age in Mice and Humans and Inhibits Osteoblast Senescence

Activation of mTORC1 in B Lymphocytes Promotes Osteoclast Formation via Regulation of β-Catenin and RANKL/OPG.

Age-related accumulation of advanced oxidation protein products promotes osteoclastogenesis through disruption of redox homeostasis

mTORC1 underlies age‐related muscle fiber damage and loss by inducing oxidative stress and catabolism

Activation of 4-1BB signaling in bone marrow stromal cells triggers bone loss via the p-38 MAPK-DKK1 axis in aged mice

RICTOR-mediated Activation of AKT/mTOR Signaling and Autophagy Inhibition Promote Osteoarthritis.

mTORC1 induces plasma membrane depolarization and promotes preosteoblast senescence by regulating the sodium channel Scn1a